thiothixene NDC 60219-1674

NDC codes

FDA NDC Directory

Product NDC (as listed)60219-1674Labeler and product segments. Claims need a package NDC.

Product NDC at billing width60219-1674Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
60219-1674-1	60219167401	100 CAPSULE in 1 BOTTLE, PLASTIC (60219-1674-1)Marketed from Mar 3, 2022
60219-1674-7	60219167407	1000 CAPSULE in 1 BOTTLE, PLASTIC (60219-1674-7)Marketed from Mar 3, 2022

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): thiothixene
Generic name (nonproprietary): thiothixene
Active ingredients: Thiothixene — 2 mg/1
Dosage form: Capsule
Route: Oral
Labeler: Amneal Pharmaceuticals NY LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 215456
Marketing start: Mar 3, 2022
Listing expires: Dec 31, 2027
Identifiers: Product ID 60219-1674_2a200fb2-9cdb-46c4-ad0f-5e3e89c3210dSPL ID 2a200fb2-9cdb-46c4-ad0f-5e3e89c3210dSPL set ID 81c40311-7dc4-4332-8920-a39a8466aea6RxCUI 313361, 313362, 313364, 313366UNII 7318FJ13YJUPC 0360219167476, 0360219167414, 0360219167377, 0360219167674, 0360219167513, 0360219167612, 0360219167575, 0360219167315
Pharmacologic class: Typical Antipsychotic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N460219167401 followed by a unit qualifier and the quantity

Package 60219-1674-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 16, 2024. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS Thiothixene capsules are effective in the management of schizophrenia. Thiothixene capsules have not been evaluated in the management of behavioral complications in patients with mental retardation.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 215456

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 215456
Product	Strength	Form · route	Labeler	Product NDC
thiothixene	Thiothixene 1 mg/1	CapsuleOral	Amneal Pharmaceuticals NY LLC	60219-1673
thiothixene	Thiothixene 10 mg/1	CapsuleOral	Amneal Pharmaceuticals NY LLC	60219-1676
thiothixene	Thiothixene 5 mg/1	CapsuleOral	Amneal Pharmaceuticals NY LLC	60219-1675